Vaccine Manufacturing News - Latest Updates & Headlines
Indian pharma exports expected to cross $30bn this year, rise sharply by 2030: Minister
New Delhi, Sep 30: India’s pharma exports, currently valued at nearly $27.8 billion, are expected to cross $30 billion by the year-end, said Union Minister of State (Independent Charge) for Science and Technology Jitendra Singh on Tuesday.
India's bioeconomy leaps from just $10 bn to $165.7 bn in 10 years
New Delhi, Sep 5: Over the past decade, India has emerged as one of the fastest-growing bioeconomies in the world, with the sector expanding to $165.7 billion in 2024 from just $10 billion in 2014. With an ambitious target of $300 billion by 2030, the bioeconomy is steadily becoming a cornerstone of India’s sustainable growth and innovation, driven by advancements in biotechnology, agricultural innovation, biomanufacturing, and healthcare.
Biological E Limited partners with Bavarian Nordic to increase global access to Chikungunya Vaccine
Hyderabad, February 25: Biological E Limited (BE) on Tuesday announced a strategic partnership with Bavarian Nordic A/S (OMX: BAVA) to expand access to Bavarian Nordic's Chikungunya Vaccine in low-and middle-income countries (LMIC).
Singapore President visits vaccine facility in Bhubaneswar
Bhubaneswar, January 19: Singapore President Tharman Shanmugaratnam visited the state-of-the-art Sapigen Biologix vaccine facility in Bhubaneswar, Odisha, which has been established with an investment of Rs 1,500 crore. The plant is expected to have the capacity to produce eight billion doses of vaccines per annum.